Search - tctmd.com

Displaying 1 - 20 of 60

Sort: Relevancy | Date

Presentation AHA 2024

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

Presenter: Oussama M. Wazni

November 16, 2024

Presentation EuroPCR 2023

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Presenter: Xavier Freixa

May 17, 2023

Presentation Miami Valves 2023

A Revolutionary Approach to Left Atrial Appendage Closure

Presenter: Saibal Kar

February 04, 2023

Presentation TCT 2022

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Presenter: Davide Cao

September 18, 2022

Presentation ARCH 2019

Innovation in AF Ablation: Better Methods / Techniques for Successful Ablation

Presenter: Andrea Natale

April 10, 2019

Presentation LAA 2017

My 3 Most Challenging Transseptal Punctures in 5 Minutes

Presenter: Brian Whisenant

July 22, 2017

Presentation LAA 2017

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Presenter: Vivek Y. Reddy

July 21, 2017

Presentation JIM 2017

Appendix Closure is the Solution

Presenter: Horst Sievert

February 10, 2017

Presentation TVT 2016

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

Presenter: Fabian Nietlispach

June 17, 2016

Presentation EuroPCR 2016

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Presenter: Jens Erik Nielsen-Kudsk

May 20, 2016

Presentation

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presenter: Vivek Y. Reddy

December 13, 2015

Presentation

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Presenter: David R. Holmes Jr

June 16, 2015

Presentation

LAA Occlusion for Stroke Prevention in A-Fib

Presenter: Apostolos Tzikas

January 29, 2015

Presentation

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Presenter: AO Badheka

December 11, 2014

Presentation

Percutaneous LAA Closure vs Warfarin for A-fib:A Randomized Clinical Trial

Presenter: Vivek Y. Reddy

November 19, 2014

Presentation

Percutaneous LAA Occlusion in Patients With Nonvalvular A-fib

Presenter: G. Santoro

November 05, 2014

Presentation Cardiovascular Interventions 2014

Left Atrial Appendage Closure for Atrial Fibrillation

Presenter: Matthew J. Price

October 23, 2014

Presentation TCT 2014

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

Presenter: Vivian Lee

September 16, 2014

Presentation TCT 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee

September 15, 2014

Presentation TCT 2014

Current (and Future) Guidelines for Atrial Fibrillation Treatment

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Ted E. Feldman

September 15, 2014

Advertisement

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

A Revolutionary Approach to Left Atrial Appendage Closure

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Innovation in AF Ablation: Better Methods / Techniques for Successful Ablation

My 3 Most Challenging Transseptal Punctures in 5 Minutes

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Appendix Closure is the Solution

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

LAA Occlusion vs Standard Care In Patients With Atrial Fibrillation And Intracerebral Hemorrhage

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

LAA Occlusion for Stroke Prevention in A-Fib

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Percutaneous LAA Closure vs Warfarin for A-fib:A Randomized Clinical Trial

Percutaneous LAA Occlusion in Patients With Nonvalvular A-fib

Left Atrial Appendage Closure for Atrial Fibrillation

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Current (and Future) Guidelines for Atrial Fibrillation Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content